Alcon's Vision Care division posted a global sales increase of 4 percent to $606 million for the fourth quarter, thanks to strong sales of contact lenses and better sales of multipurpose products against a weak quarter for them in 2011. Alcon is the second-largest division of the Novartis group portfolio, ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.